RNA Processing in Cancer Conference: From Bench to Bedside

摘要 RNA加工的改变最近已经成为一个新的癌症标志和一个有希望的靶点 癌症疗法。癌症和RNA生物学领域传统上是孤立研究的；然而， 需要这些领域之间的综合方法来培养下一代科学家和医生 来揭开他们关系的机制。目前，在癌症领域还没有一次会议使用rna。 生物学。为了填补这一空白，我们提出了独一无二的、及时的跨学科会议--FASEB RNA处理 在癌症：从长凳到床边“，以促进未来的合作和研究进展。主要目标 这次会议的目的是确定RNA加工在癌症发生、进展和药物反应中的作用， 并确定针对癌症中RNA加工缺陷的新治疗策略。这5天的时间 会议将于2023年11月在德克萨斯州休斯顿举行，届时包括研究生在内的科学家将齐聚一堂 学生、博士后研究员、初级和高级调查人员以及临床医生和内科医生，以及 来自工业和制药公司，来自RNA生物学和癌症领域的科学家。在推杆的同时 结合发言者名单，组委会承诺增加多样性。这次会议 课程将包括特邀讲座、实习生的简短演讲以及教育/专业会议，内容包括 具有独特专业知识但对了解RNA加工在癌症中的作用有共同兴趣的领先科学家 致病机制和开发新的癌症治疗方法。我们的具体目标是：(1)组织 关于RNA加工和癌症的跨学科会议；(2)促进互动，促进协作 研究和职业发展；(3)促进招聘和发展不同的初级调查员 RNA生物学和癌症研究领域；(4)加速将基础进展转化为新的临床 癌症治疗学。拟议的会议将交叉授粉RNA生物学和癌症生物学领域， 为跨学科的新协作提供种子，并促进下一代科学家实施 在肿瘤学中针对RNA加工的策略。

SUMMARY Alterations in RNA processing have recently emerged as a new cancer hallmark and a promising target for cancer therapies. The fields of cancer and RNA biology have traditionally been studied in isolation; however, an integrated approach between these fields is needed to prepare the next generation of scientists and physicians to uncover the mechanisms of their relationship. Currently, no conference in the cancer field incorporates RNA biology. To fill this gap, we propose the unique and timely interdisciplinary conference “FASEB RNA processing in cancer: from bench to bedside” to foster future collaborations and research advances. The main objectives of this meeting are to define the role of RNA processing in cancer initiation, progression, and drug responses, and to identify novel therapeutic strategies to target RNA processing defects in cancer. This 5-day long conference to be held in Houston, TX in November 2023 will bring together scientists, including graduate students, postdoctoral fellows, and junior and senior investigators, as well as clinicians and physicians, and scientists from industry and pharmaceutical companies, from the fields of RNA biology and cancer. While putting together the speakers list, the organizing committee made a commitment to increased diversity. The conference program will include invited lectures, short talks from trainees, and educational/professional sessions, featuring leading scientists with distinct expertise yet shared interest in understanding the role of RNA processing in cancer pathogenesis and developing novel cancer therapeutics. Our specific aims are to (1) Organize an interdisciplinary conference on RNA processing and cancer; (2) Promote interactions to foster collaborative research and career advancement; (3) Foster the recruitment and development of diverse junior investigators in RNA biology and cancer research fields; (4) Accelerate translation of fundamental advances into novel clinical cancer therapeutics. The proposed conference will cross-pollinate the fields of RNA biology and cancer biology, seed new collaborations across disciplines, and facilitate the next generation of scientists to implement novel strategies towards targeting RNA processing in oncology.